Literature DB >> 8369465

Myocardial dysfunction following cardiopulmonary bypass: recovery patterns, predictors of inotropic need, theoretical concepts of inotropic administration.

R L Royster1.   

Abstract

Clinical myocardial dysfunction following cardiopulmonary bypass commonly occurs in patients with good preoperative ventricular function. Following separation from cardiopulmonary bypass, ventricular function improves initially, but then begins to worsen and reaches a nadir between 4 and 6 hours after surgery with full recovery occurring around 24 hours postoperatively. However, in patients with preoperative ventricular dysfunction, the depression of ventricular function is more severe and recovery is longer. Despite this high frequency of myocardial dysfunction, many patients do well without requiring pharmacologic intervention after cardiopulmonary bypass to augment contractility and peripheral perfusion. Factors that may predict the need for inotropic support in patients following cardiopulmonary bypass include low ejection fraction, older age, cardiac enlargement, female sex, the length of cardiopulmonary bypass and the duration of aortic cross-clamping. The patient with preoperative ventricular dysfunction has many of these preoperative and intraoperative predictors for inotropic support. The pharmacologic regimen to support the myocardium during the recovery period following cardiopulmonary bypass must take into consideration the pathophysiologic processes of chronic congestive heart failure and reperfusion injury. Reduction of cyclic adenosine monophosphate (cAMP) levels is a fundamental problem in congestive heart failure and results from either down-regulation of beta-receptors or a defect in the G-regulatory proteins controlling adenylyl cyclase production. This diminishes the effectiveness of agents dependent on cAMP to produce an inotropic response. However, amplification of the reduced cAMP produced by beta-agonists may occur in association with the inhibition of cAMP breakdown resulting from phosphodiesterase inhibitors. All inotropic agents are usually effective in reversing the reperfusion-induced stunned myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369465     DOI: 10.1016/1053-0770(93)90093-z

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  8 in total

1.  Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized controlled trials.

Authors:  Victor F Seabra; Sami Alobaidi; Ethan M Balk; Alan H Poon; Bertrand L Jaber
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 8.237

2.  An individualized recruitment maneuver for mechanically ventilated patients after cardiac surgery.

Authors:  Ryohei Serita; Hiroshi Morisaki; Junzo Takeda
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

3.  Anaesthetic induction in a child with end-stage cardiomyopathy.

Authors:  W S Schechter; C Kim; M Martinez; B F Gleason; D P Lund; F A Burrows
Journal:  Can J Anaesth       Date:  1995-05       Impact factor: 5.063

4.  Effects of transcutaneous electrical nerve stimulation on myocardial protection in patients undergoing aortic valve replacement: a randomized clinical trial.

Authors:  Youn Joung Cho; Dhong-Eun Jung; Karam Nam; Jinyoung Bae; Seohee Lee; Yunseok Jeon
Journal:  BMC Anesthesiol       Date:  2022-03-09       Impact factor: 2.217

5.  Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB).

Authors:  Imdad Ahmed; Chad M House; William B Nelson
Journal:  J Cardiothorac Surg       Date:  2009-06-12       Impact factor: 1.637

Review 6.  Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury.

Authors:  Aida Salameh; Stefan Dhein
Journal:  Front Pharmacol       Date:  2015-12-22       Impact factor: 5.810

7.  Ministernotomy or sternotomy in isolated aortic valve replacement? Early results.

Authors:  Grzegorz Filip; Magdalena A Bryndza; Janusz Konstanty-Kalandyk; Jacek Piatek; Piotr Wegrzyn; Piotr Ceranowicz; Maciej Brzezinski; Dhanunjaya Lakkireddy; Boguslaw Kapelak; Krzysztof Bartuś
Journal:  Kardiochir Torakochirurgia Pol       Date:  2018-12-31

8.  Anti-oxidative or anti-inflammatory additives reduce ischemia/reperfusions injury in an animal model of cardiopulmonary bypass.

Authors:  Aida Salameh; Stefan Dhein; Marie Mewes; Sophie Sigusch; Philipp Kiefer; Marcel Vollroth; Johannes Seeger; Ingo Dähnert
Journal:  Saudi J Biol Sci       Date:  2019-04-05       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.